Lipoprotein(a): Implications for clinical practice
Department of Community and Preventive Medicine, University of Rochester Medical Center, Rochester, NY 14627, USA.Current Atherosclerosis Reports (Impact Factor: 3.42). 10/2005; 7(5):327-9. DOI: 10.1007/s11883-005-0041-1
- [Show abstract] [Hide abstract]
ABSTRACT: Lipoprotein(a) [Lp(a)] is a lipoprotein subclass well-known among the lipid community to accelerate atherosclerosis and promote thrombosis through incompletely understood mechanism. We report a case of a young man with a healthy lifestyle and no major coronary or vascular risk factors who presented to the emergency department with an acute coronary syndrome and was ultimately found to have severe coronary artery disease. A diagnostic workup revealed elevated Lp(a). He was treated with consequent reduction in Lp(a) concentration. This case highlights the need to better understand atypical lipoproteins, how they relate to cardiovascular disease, the implications for screening family members, and the need to standardize patient management guidelines for the purpose of mortality risk reduction.Journal of Clinical Lipidology 09/2013; 7(5):526-530. DOI:10.1016/j.jacl.2013.05.005 · 3.90 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.